| Aug 18, 2026 | Robert Hershberg | DIRECTOR | SELL | 15.664K | $15.36 | $653K |
| Aug 17, 2026 | Chad M Robins | CEO AND CHAIRMAN | SELL-OPTIONS | — | $15.68 | $11.0M |
| Aug 17, 2026 | Peter M Neupert | DIRECTOR | SELL | 109.690K | $15.73 | $3.0M |
| Aug 10, 2026 | Susan Bobulsky | CHIEF COMMERCIAL OFFICER, MRD | SELL | 3.000K | $25.00 | $75K |
| Jul 30, 2026 | Susan Bobulsky | CHIEF COMMERCIAL OFFICER, MRD | SELL | 1.299K | $24.00 | $31K |
| Jul 21, 2026 | Harlan S Robins | CHIEF SCIENTIFIC OFFICER | SELL | 207.600K | $14.22 | $8.9M |
| Jul 16, 2026 | Susan Bobulsky | CHIEF COMMERCIAL OFFICER, MRD | SELL | 5.000K | $23.00 | $115K |
| Jul 15, 2026 | Francis Lo | CHIEF PEOPLE OFFICER | SELL-OPTIONS | — | $15.75 | $1.4M |
| Jul 2, 2026 | Harlan S Robins | CHIEF SCIENTIFIC OFFICER | SELL | 386.240K | $22.01 | $8.5M |
| Jul 1, 2026 | Francis Lo | CHIEF PEOPLE OFFICER | SELL | 20.221K | $15.63 | $1.5M |
| Jul 1, 2026 | Susan Bobulsky | CHIEF COMMERCIAL OFFICER, MRD | SELL | 487.000 | $22.00 | $11K |
| Jun 26, 2026 | Sharon Benzeno | CHIEF COMMERCIAL OFC IMM MED | SELL | 51.473K | $14.44 | $2.6M |
| Jun 25, 2026 | Susan Bobulsky | CHIEF COMMERCIAL OFFICER, MRD | SELL | 5.000K | $20.50 | $103K |
| Jun 25, 2026 | Michelle Renee Griffin | DIRECTOR | SELL-OPTIONS | — | $13.99 | $645K |
| Jun 15, 2026 | Harlan S Robins | CHIEF SCIENTIFIC OFFICER | SELL | 106.160K | $17.41 | $1.8M |
| Jun 11, 2026 | Susan Bobulsky | CHIEF COMMERCIAL OFFICER, MRD | SELL | 5.000K | $19.00 | $95K |
| Jun 4, 2026 | Francis Lo | CHIEF PEOPLE OFFICER | SELL | 20.220K | $13.17 | $522K |
| Jun 4, 2026 | Susan Bobulsky | CHIEF COMMERCIAL OFFICER, MRD | SELL | 11.000K | $18.00 | $198K |
| May 18, 2026 | Kyle Piskel | CHIEF FINANCIAL OFFICER | SELL | 3.115K | $13.04 | $41K |
| Apr 27, 2026 | Julie Rubinstein | PRESIDENT AND COO | SELL | 4.330K | $11.35 | $146K |
| Apr 22, 2026 | Julie Rubinstein | PRESIDENT AND COO | SELL | 13.014K | $11.21 | $425K |
| Apr 17, 2026 | Julie Rubinstein | PRESIDENT AND COO | SELL | 13.014K | $11.92 | $491K |
| Apr 14, 2026 | Julie Rubinstein | PRESIDENT AND COO | SELL | 13.014K | $11.46 | $453K |
| Apr 9, 2026 | Julie Rubinstein | PRESIDENT AND COO | SELL | 13.014K | $10.35 | $429K |
| Apr 8, 2026 | Francis Lo | CHIEF PEOPLE OFFICER | SELL | 20.220K | $9.53 | $331K |
| Apr 8, 2026 | Harlan S Robins | CHIEF SCIENTIFIC OFFICER | SELL | 10.000K | $14.85 | $149K |
| Apr 6, 2026 | Chad M Robins | CEO AND CHAIRMAN | SELL | 120.595K | $14.65 | $1.8M |
| Apr 6, 2026 | Julie Rubinstein | PRESIDENT AND COO | SELL | 13.014K | $11.32 | $525K |
| Apr 1, 2026 | Julie Rubinstein | PRESIDENT AND COO | SELL | 8.676K | $10.90 | $340K |
| Mar 27, 2026 | Julie Rubinstein | PRESIDENT AND COO | SELL | 13.014K | $10.20 | $430K |
| Mar 24, 2026 | Julie Rubinstein | PRESIDENT AND COO | SELL | 13.014K | $10.65 | $481K |
| Mar 19, 2026 | Julie Rubinstein | PRESIDENT AND COO | SELL | 13.014K | $10.21 | $462K |
| Mar 16, 2026 | Julie Rubinstein | PRESIDENT AND COO | SELL | 13.014K | $9.94 | $473K |
| Mar 11, 2026 | Julie Rubinstein | PRESIDENT AND COO | SELL | 135.537K | $9.88 | $2.1M |
| Mar 11, 2026 | Michelle Renee Griffin | DIRECTOR | SELL | 15.394K | $13.91 | $214K |
| Mar 11, 2026 | Francis Lo | CHIEF PEOPLE OFFICER | SELL | 30.593K | $14.08 | $431K |
| Mar 11, 2026 | Susan Bobulsky | CHIEF COMMERCIAL OFFICER, MRD | SELL | 41.338K | $13.17 | $544K |
| Mar 11, 2026 | Sharon Benzeno | CHIEF COMMERCIAL OFC IMM MED | SELL | 63.103K | $13.17 | $831K |
| Mar 11, 2026 | Kyle Piskel | CHIEF FINANCIAL OFFICER | SELL | 18.672K | $13.17 | $246K |
| Mar 11, 2026 | Harlan S Robins | CHIEF SCIENTIFIC OFFICER | SELL | 470.266K | $13.17 | $6.2M |
| Mar 11, 2026 | Chad M Robins | CEO AND CHAIRMAN | SELL | 470.167K | $13.17 | $6.2M |
| Mar 6, 2026 | Julie Rubinstein | PRESIDENT AND COO | SELL | 13.014K | $11.71 | $629K |
| Mar 5, 2026 | Francis Lo | CHIEF PEOPLE OFFICER | SELL | 38.074K | $15.09 | $575K |
| Mar 3, 2026 | Michelle Griffin | DIRECTOR | SELL-OPTIONS | — | $9.64 | $543K |
| Mar 3, 2026 | Julie Rubinstein | PRESIDENT AND COO | SELL | 13.014K | $12.57 | $771K |
| Mar 2, 2026 | Harlan S Robins | CHIEF SCIENTIFIC OFFICER | SELL | 24.233K | $16.19 | $392K |
